Chargement en cours...
Cdk2-Null Mice Are Resistant to ErbB-2-Induced Mammary Tumorigenesis
The concept of targeting G(1) cyclin-dependent kinases (CDKs) in breast cancer treatments is supported by the fact that the genetic ablation of Cdk4 had minimal impacts on normal cell proliferation in majority of cell types, resulting in near-normal mouse development, whereas such loss of Cdk4 compl...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Neoplasia Press Inc.
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3084620/ https://ncbi.nlm.nih.gov/pubmed/21532884 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|